Literature DB >> 2055106

Detection of trisomy 8 in hematological disorders by in situ hybridization.

R E Kibbelaar1, H van Kamp, E J Dreef, J W Wessels, G C Beverstock, A K Raap, W E Fibbe, G J den Ottolander, P M Kluin.   

Abstract

An alphoid repetitive DNA (D8Z2) probe specific for the pericentromeric region of chromosome 8 was used to detect extra copies of chromosome 8 in bone marrow cells obtained from 10 patients with hematological disorders and five controls. Numerical aberrations of chromosome 8 were established by conventional banding techniques. Trisomy 8 was found in four patients with myelodysplastic syndrome (MDS) and three with acute myeloid leukemia (AML). Three additional patients with MDS exhibited an extra chromosome 8 in only one metaphase. In five of the seven trisomy cases, the presence of the trisomy 8 clone was confirmed by in situ hybridization (ISH). In one case of AML with trisomy 8, detected by GTG-banding, no significant numbers of cells containing three spots were found using the alphoid repetitive probe; however, hybridization with a chromosome 8-specific library revealed that the alleged extra chromosome 8 was a translocation chromosome containing only the long arm of chromosome 8. Due to a lack of material, it was not possible to achieve optimal ISH results on the trisomy 8 bone marrow cells of patient 7. In the three MDS patients with a single trisomy 8 metaphase, a slight, albeit significant, increase of trisomy 8 interphase cells was found with ISH. We conclude that this probe is useful for cytogenetic studies. Moreover, ISH, in general, is a powerful tool for precise classification of chromosomal aberrations and can also contribute significantly to the clinical evaluation of patients with hematological disorders.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2055106     DOI: 10.1159/000133069

Source DB:  PubMed          Journal:  Cytogenet Cell Genet        ISSN: 0301-0171


  9 in total

1.  Biopsy specimen identification by detection of sex chromosomes: application of in situ hybridisation.

Authors:  R E Kibbelaar; C F Leenheers-Binnendijk; P J Spaander; P M Kluin
Journal:  J Clin Pathol       Date:  1992-02       Impact factor: 3.411

Review 2.  CCD microscopy and image analysis of cells and chromosomes stained by fluorescence in situ hybridization.

Authors:  H J Tanke; R J Florijn; J Wiegant; A K Raap; J Vrolijk
Journal:  Histochem J       Date:  1995-01

3.  Efficacy and applicability of interphase fluorescence in situ hybridization for prenatal diagnosis.

Authors:  S Schwartz
Journal:  Am J Hum Genet       Date:  1993-05       Impact factor: 11.025

Review 4.  Detection of genomic changes in cancer by in situ hybridization.

Authors:  A H Hopman; C E Voorter; F C Ramaekers
Journal:  Mol Biol Rep       Date:  1994-01       Impact factor: 2.316

Review 5.  The aneuploidy paradox: costs and benefits of an incorrect karyotype.

Authors:  Jason M Sheltzer; Angelika Amon
Journal:  Trends Genet       Date:  2011-08-26       Impact factor: 11.639

6.  Incidence of chromosome numerical changes in multiple myeloma: fluorescence in situ hybridization analysis using 15 chromosome-specific probes.

Authors:  D Tabernero; J F San Miguel; M Garcia-Sanz; L Nájera; M García-Isidoro; J A Peréz-Simon; M Gonzalez; J Wiegant; A K Raap; A Orfão
Journal:  Am J Pathol       Date:  1996-07       Impact factor: 4.307

7.  Application of fluorescence in situ hybridisation to chromosome analysis of aged bone marrow smears.

Authors:  D W Hammond; R F Hinchliffe; M H Goyns; A M Potter; J S Lilleyman
Journal:  J Clin Pathol       Date:  1994-06       Impact factor: 3.411

8.  Modification of rhodamine staining allows identification of hematopoietic stem cells with preferential short-term or long-term bone marrow-repopulating ability.

Authors:  J M Zijlmans; J W Visser; K Kleiverda; P M Kluin; R Willemze; W E Fibbe
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-12       Impact factor: 11.205

9.  Interphase cytogenetics of prostate cancer: fluorescence in situ hybridisation (FISH) analysis of Japanese cases.

Authors:  H Matsuura; T Shiraishi; R Yatani; J Kawamura
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.